OOIR: Observatory of International Research

Papers

(The H4-Index of European Respiratory Review is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Protecting healthcare workers from SARS-CoV-2 infection: practical indications	270
The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies	146
Sex and gender in asthma	126
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management	101
Post-acute COVID-19 syndrome	97
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis	86
COVID-19 pneumonia: pathophysiology and management	82
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis	80
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)	75
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea	74
Minimal clinically important difference for asthma endpoints: an expert consensus report	71
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes	67
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease	66
Developments in lung transplantation over the past decade	65
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety	61
Clinical significance and applications of oscillometry	60
Mitochondrial dysfunction in lung ageing and disease	54
Asthma and COVID-19: an update	52
The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review	50
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	48
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?	48
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	47
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review	45
Artificial intelligence in pulmonary medicine: computer vision, predictive model and COVID-19	43
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	42

Bidirectional relationships of comorbidity with obstructive sleep apnoea	42
Birt–Hogg–Dubé syndrome	41
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	41
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	39
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	38
Current evidence for COVID-19 therapies: a systematic literature review	37
Chronic cough: new insights and future prospects	37
Lung transplantation for interstitial lung disease	36
Recent developments in the treatment of small cell lung cancer	36
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	36
Update on biology and management of mesothelioma	35